Stock listing

Adalta Ltd.

Selected listing: 1AD · ASX · AUD · AU

Adalta Ltd. (ASX:1AD), Health Technology. Latest release Oct 4, 2026: EW-001 JDC milestone approvals.

1AD:ASXAUDAUUpdated October 2, 2026
Adalta Ltd. logo
Ticker
ASX:1AD
Asset type
Stock
Sector
Health Technology
Industry
Biotechnology
Exchange
ASX
Currency
AUD

About Adalta Ltd.

Adalta Ltd. is a public company listed on the Australian market under the ticker 1AD. Adalta focuses on developing innovative therapies and technologies in the biotechnology sector.

Latest news from Adalta Ltd.

EW-001 JDC milestone approvals

October 4, 2026

China Representative Office opens

September 30, 2026

US FDA grants EW-001 pre-IND meeting

September 22, 2026

Oribiotech deal validates AdAlta manufacturing strategy

September 17, 2026

BZDS1901 special access scheme launch in China

September 1, 2026

All Adalta Ltd. news →

Research Adalta Ltd.

Adalta Ltd. company profile

View the public company page for Adalta Ltd. on 6ix.

Adalta Ltd. news

Read company news and market updates connected to Adalta Ltd..

Adalta Ltd. investor events

Find investor webinars, events, and replay context for Adalta Ltd..

Alternate listings

JDA:FWB

DE · EUR

Alternate listing for Adalta Ltd.; the primary context on this page is 1AD:ASX.